Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Richmond Owusu

Biographic Data

ID8376414
NAMERichmond Owusu
GIVEN NAMESRichmond
FAMILY NAMEOwusu
SIGNATUREOWUSU R
AFFILIATIONSUniversity of Ghana
ORCID0000-0002-0066-3491
VERIFIEDYes
TOTAL WORKS11
TOTAL CITATIONS0
WORKS AS AUTHOR11
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Beyond aspiration

    Open Access•Alex Adjagba, Jacob Novignon et al.•ARTICLE•PLOS Global Public Health•2026

    In 2001, African Union (AU) member states committed to allocating 15% of their annual budget to health under the Abuja Declaration (AD). However, after more than two decades, health allocations across many countries still fall short of the target. This study uses an expenditure-based proxy for the AD to examine the likelihood and timing of attainment of the benchmark under historical fiscal trajectories.We compiled a 2002–2023 panel for 54 Africa…

  • Optimizing health, financial risk protection, and equity in health benefits package design toward universal health coverage

    Open Access•Boshen Jiao, Sophia Houhamdi et al.•ARTICLE•Social Science & Medicine•2026

  • Estimating the opportunity cost of seasonal malaria chemoprevention implementation in Burkina Faso, Mali and Senegal

    Open Access•Richmond Owusu, Colin Gilmartin et al.•ARTICLE•BMJ Global Health•2025

    Background Seasonal malaria chemoprevention (SMC) is a widely implemented malaria prevention strategy for children under five in the Sahel and sub-Sahel regions of Africa. This study aimed to estimate the full opportunity costs associated with SMC implementation in Mali, Burkina Faso and Senegal, addressing a gap in existing research that often focused solely on health system costs. Using a repeated descriptive cross-sectional design, data were c…

  • Household economic burden of managing people living with HIV and comorbidities of hypertension and diabetes in La Nkwantanang-Madina Municipality, Ghana

    Open Access•Richmond Owusu, Esther Esi Degbor et al.•ARTICLE•PLOS Global Public Health•2025

    Managing HIV alongside chronic conditions such as hypertension and diabetes present significant economic challenges for households, especially in low-and middle-income countries. These chronic diseases not only reduce the quality of life of people living with HIV (PLHIV) but also further increase their economic burden. This study seeks to examine the economic burden of managing PLHIV with hypertension and diabetes comorbidities. The cross-section…

  • Achieving universal coverage of childhood cancers in Ghana via the National Health Insurance Scheme

    Open Access•Richmond Owusu, Lieke Fleur Heupink et al.•ARTICLE•PLOS Global Public Health•2025

    Childhood cancers present a significant health problem and contribute to global child mortality. Low- and middle-income countries experience higher rates of childhood cancers with survival rates between 10% and 50%. In Ghana, about 2,500 children are diagnosed with cancer annually. Despite availability of effective management strategies, childhood cancers are not fully integrated into the NHIS, leaving patients and caregivers to make out-of-pocke…

  • Health-related quality of life of HIV patients with comorbidities of hypertension or diabetes in Ghana

    Open Access•Richmond Owusu, Emmanuel Bugyei Kwarteng et al.•ARTICLE•Frontiers in Public Health•2024

    Background Clinical studies, particularly in the context of HIV/AIDS, have utilized health-related quality of life (HRQoL) and health state utility values to assess both clinical and economic implications. Improvement in HIV management with antiretroviral therapy (ART) has coincided with an increased morbidity of chronic conditions such as diabetes and hypertension among people living with HIV. The study offers empirical evidence establishing a l…

  • Sustainability of pneumococcal conjugate vaccination in Ghana

    Open Access•Abdul-Mumin Ibrahim, Ahmadu Ibrahim et al.•ARTICLE•Frontiers in Public Health•2024

    Background: Streptococcus pneumonia is responsible for 18% of infant deaths in Ghana. With co-financing from Gavi in 2012, Ghana introduced the PCV13 into the childhood immunization programme to reduce the burden of Streptococcus pneumonia. However, Ghana will graduate to the Gavi fully self-financing phase in 2026, when the nation assumes full responsibility of paying for the PCV13. This research aims to evaluate the health impact and cost-effec…

  • Assessment of occupational stress among certified registered anesthetists in the Greater Accra region

    Open Access•Dorcas Edem Sabblah, Abdulai Mohammed Salifu et al.•ARTICLE•Frontiers in Public Health•2024

    Background Work-related stress is a prevailing concern within the community of Certified Registered Anesthetists (CRAs), significantly impacting both the health and professional performance of these individuals. This study aimed to assess work-related stress and its influencing factors among CRAs practicing in the Greater Accra region was examined. Methods Using convenience sampling techniques, data were gathered from 140 participants via a Googl…

  • The epidemiological and economic burden of diabetes in Ghana

    Open Access•Joseph Kazibwe, Mohamed Gad et al.•ARTICLE•PLOS Global Public Health•2024

    Diabetes remains one of the four major causes of morbidity and mortality globally among non-communicable diseases (NCDs. It is predicted to increase in sub–Saharan Africa by over 50% by 2045. The aim of this study is to identify, map and estimate the burden of diabetes in Ghana, which is essential for optimising NCD country policy and understanding existing knowledge gaps to guide future research in this area. We followed the Arksey and O’Malley …

  • Rotavirus vaccine product switch in Ghana

    Open Access•Richmond Owusu, Mercy Mvundura et al.•ARTICLE•PLOS Global Public Health•2023

    Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint but requires more doses per regimen (three versus two). This study estimates the supply chain and service delivery costs associated with each product,…

  • Fairer financing of vaccines in a world living with Covid-19

    Open Access•Itamar Megiddo, Justice Nonvignon et al.•ARTICLE•BMJ Global Health•2020

    The COVID-19 pandemic has disrupted routine and campaign-based vaccination, potentially increasing the future vaccine-preventable disease burden and threatening to overwhelm health systems.\n\n- Vaccine-preventable diseases are transboundary problems that require global cooperation to achieve the best outcomes.\n\n- Investments, predominantly by rich countries—in effect transfers to poor countries—are required as part of the financing solution. T…

No prominent works on this page.

  • Fairer financing of vaccines in a world living with Covid-19

    Open Access•Itamar Megiddo, Justice Nonvignon et al.•ARTICLE•BMJ Global Health•2020

    The COVID-19 pandemic has disrupted routine and campaign-based vaccination, potentially increasing the future vaccine-preventable disease burden and threatening to overwhelm health systems.\n\n- Vaccine-preventable diseases are transboundary problems that require global cooperation to achieve the best outcomes.\n\n- Investments, predominantly by rich countries—in effect transfers to poor countries—are required as part of the financing solution. T…

  • Rotavirus vaccine product switch in Ghana

    Open Access•Richmond Owusu, Mercy Mvundura et al.•ARTICLE•PLOS Global Public Health•2023

    Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint but requires more doses per regimen (three versus two). This study estimates the supply chain and service delivery costs associated with each product,…

  • Health-related quality of life of HIV patients with comorbidities of hypertension or diabetes in Ghana

    Open Access•Richmond Owusu, Emmanuel Bugyei Kwarteng et al.•ARTICLE•Frontiers in Public Health•2024

    Background Clinical studies, particularly in the context of HIV/AIDS, have utilized health-related quality of life (HRQoL) and health state utility values to assess both clinical and economic implications. Improvement in HIV management with antiretroviral therapy (ART) has coincided with an increased morbidity of chronic conditions such as diabetes and hypertension among people living with HIV. The study offers empirical evidence establishing a l…

  • Sustainability of pneumococcal conjugate vaccination in Ghana

    Open Access•Abdul-Mumin Ibrahim, Ahmadu Ibrahim et al.•ARTICLE•Frontiers in Public Health•2024

    Background: Streptococcus pneumonia is responsible for 18% of infant deaths in Ghana. With co-financing from Gavi in 2012, Ghana introduced the PCV13 into the childhood immunization programme to reduce the burden of Streptococcus pneumonia. However, Ghana will graduate to the Gavi fully self-financing phase in 2026, when the nation assumes full responsibility of paying for the PCV13. This research aims to evaluate the health impact and cost-effec…

  • Assessment of occupational stress among certified registered anesthetists in the Greater Accra region

    Open Access•Dorcas Edem Sabblah, Abdulai Mohammed Salifu et al.•ARTICLE•Frontiers in Public Health•2024

    Background Work-related stress is a prevailing concern within the community of Certified Registered Anesthetists (CRAs), significantly impacting both the health and professional performance of these individuals. This study aimed to assess work-related stress and its influencing factors among CRAs practicing in the Greater Accra region was examined. Methods Using convenience sampling techniques, data were gathered from 140 participants via a Googl…

  • The epidemiological and economic burden of diabetes in Ghana

    Open Access•Joseph Kazibwe, Mohamed Gad et al.•ARTICLE•PLOS Global Public Health•2024

    Diabetes remains one of the four major causes of morbidity and mortality globally among non-communicable diseases (NCDs. It is predicted to increase in sub–Saharan Africa by over 50% by 2045. The aim of this study is to identify, map and estimate the burden of diabetes in Ghana, which is essential for optimising NCD country policy and understanding existing knowledge gaps to guide future research in this area. We followed the Arksey and O’Malley …

  • Estimating the opportunity cost of seasonal malaria chemoprevention implementation in Burkina Faso, Mali and Senegal

    Open Access•Richmond Owusu, Colin Gilmartin et al.•ARTICLE•BMJ Global Health•2025

    Background Seasonal malaria chemoprevention (SMC) is a widely implemented malaria prevention strategy for children under five in the Sahel and sub-Sahel regions of Africa. This study aimed to estimate the full opportunity costs associated with SMC implementation in Mali, Burkina Faso and Senegal, addressing a gap in existing research that often focused solely on health system costs. Using a repeated descriptive cross-sectional design, data were c…

  • Household economic burden of managing people living with HIV and comorbidities of hypertension and diabetes in La Nkwantanang-Madina Municipality, Ghana

    Open Access•Richmond Owusu, Esther Esi Degbor et al.•ARTICLE•PLOS Global Public Health•2025

    Managing HIV alongside chronic conditions such as hypertension and diabetes present significant economic challenges for households, especially in low-and middle-income countries. These chronic diseases not only reduce the quality of life of people living with HIV (PLHIV) but also further increase their economic burden. This study seeks to examine the economic burden of managing PLHIV with hypertension and diabetes comorbidities. The cross-section…

  • Achieving universal coverage of childhood cancers in Ghana via the National Health Insurance Scheme

    Open Access•Richmond Owusu, Lieke Fleur Heupink et al.•ARTICLE•PLOS Global Public Health•2025

    Childhood cancers present a significant health problem and contribute to global child mortality. Low- and middle-income countries experience higher rates of childhood cancers with survival rates between 10% and 50%. In Ghana, about 2,500 children are diagnosed with cancer annually. Despite availability of effective management strategies, childhood cancers are not fully integrated into the NHIS, leaving patients and caregivers to make out-of-pocke…

  • Beyond aspiration

    Open Access•Alex Adjagba, Jacob Novignon et al.•ARTICLE•PLOS Global Public Health•2026

    In 2001, African Union (AU) member states committed to allocating 15% of their annual budget to health under the Abuja Declaration (AD). However, after more than two decades, health allocations across many countries still fall short of the target. This study uses an expenditure-based proxy for the AD to examine the likelihood and timing of attainment of the benchmark under historical fiscal trajectories.We compiled a 2002–2023 panel for 54 Africa…

  • Optimizing health, financial risk protection, and equity in health benefits package design toward universal health coverage

    Open Access•Boshen Jiao, Sophia Houhamdi et al.•ARTICLE•Social Science & Medicine•2026

Medicine (7 works) · Environmental health (6 works) · Business (4 works) · Family medicine (4 works) · Diabetes mellitus (3 works) · Economic growth (3 works) · Economics (3 works) · Gerontology (3 works) · Health care (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae